Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome
<b>Background/Objectives</b>: Early diagnosis and oral or, in severe cases, intravenous antibiotics are usually effective for Lyme disease, but some patients have persistent symptoms unresponsive to standards of care, requiring alternative therapies. Disulfiram (DIS), a drug for alcoholi...
Saved in:
| Main Authors: | Beáta-Mária Benkő, Bálint-Imre Szabó, Szabina Kádár, Edina Szabó, Gergő Tóth, Lajos Szente, Péter Tonka-Nagy, Romána Zelkó, István Sebe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/7/849 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A pilot study of disulfiram for individuals with persistent symptoms despite prior antibiotic treatment for Lyme disease
by: Mara Kuvaldina, et al.
Published: (2025-04-01) -
Structure of inclusion complex of disulfiram with hydroxypropyl-β-cyclodextrin
by: V. S. Tyukova, et al.
Published: (2015-10-01) -
STANDARDIZATION OF INCLUSION COMPLEX OF DISULFIRAM WITH HYDROXYPROPYL-β-CYCLODEXTRIN FOR USE AS PHARMACEUTICAL SUBSTANCES
by: S. A. Kedik, et al.
Published: (2019-01-01) -
MODERN ASPECTS OF SUPPOSITORIES MANUFACTURING
by: N. B. Diomina
Published: (2019-01-01) -
Disulfiram-induced polyneurophaty
by: Vujisić Slavica, et al.
Published: (2012-01-01)